(Q40493589)

English

Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization (English)

1 reference

Europe PubMed Central

21 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Michael J Wichroski

1

1 reference

Europe PubMed Central

21 September 2017

Kozi Ichiyama

2

1 reference

Europe PubMed Central

21 September 2017

Tariq M Rana

3

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

10 November 2004

1 reference

Europe PubMed Central

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

21 September 2017

280

1 reference

Europe PubMed Central

21 September 2017

8387-8396

1 reference

Europe PubMed Central

21 September 2017

9

1 reference

Europe PubMed Central

21 September 2017

The viral infectivity factor (Vif) of HIV-1 unveiled

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The interaction between HIV-1 Gag and APOBEC3G.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Death by Deamination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Incorporation of uracil into minus strand DNA affects the specificity of plus strand synthesis initiation during lentiviral reverse transcription

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Aggresomes, inclusion bodies and protein aggregation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

The proteasome regulates receptor-mediated endocytosis of interleukin-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Visualization of the intracellular behavior of HIV in living cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Feline immunodeficiency virus Vif localizes to the nucleus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408048200

21 January 2018

Identifiers

10.1074/JBC.M408048200

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40493589&oldid=2033546674"